MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    A precompetitive consortium approach to designing a qualitative study to generate content validity evidence to support the use of digital health technologies among people with early Parkinson’s disease

    R. Speck, J. Mammen, P. Yang, S. Jensen-Roberts, M. Kostrzebski, R. Dorsey, M. Müller, J. Cosman, J. Hellsten, J. Crawford, G. Stebbins, J. Cedarbaum, T. Simuni, T. Dam, K. Ward Barowicz, D. Stephenson, J. Adams (Tucson, USA)

    Objective: To understand from the patient perspective the relevance and comprehensiveness of the performance outcome (PerfO) measures administered via digital health technologies (DHTs) in the…
  • 2022 International Congress

    Motor, epileptic, and developmental phenotypes in genetic disorders affecting G-protein coupled receptor signaling and cAMP metabolism

    S. Galosi, L. Pollini, M. Novelli, K. Bernardi, M. Di Rocco, S. Martinelli, V. Leuzzi (Rome, Italy)

    Objective: To provide a detailed clinical characterization of genetic disorders affecting G-protein coupled receptor signaling and cAMP metabolism Background: Genetic disorders affecting G-protein coupled receptor (GPCRs) signaling…
  • 2022 International Congress

    Safety and Efficacy of Verdiperstat, a Novel Myeloperoxidase Inhibitor, in MSA

    I. Qureshi, V. Wirtz, L. Brady, J. Ellison, A. Ellenbogen, R. Freeman, G. Höglinger, H. Kaufmann, A. Lang, P. Low, W. Meissner, P. Millar Vernetti, H. Morris, J. Palma, S. Perlman, W. Poewe, J. Schmahmann, K. Seppi, W. Singer, S. Vernino, G. Wenning (New Haven, USA)

    Objective: To present results from M-STAR, a phase 3, randomized controlled trial evaluating the disease modifying effect of verdiperstat in participants with MSA. Background: MSA…
  • 2022 International Congress

    Temporal Dynamic Alterations of Regional Homogeneity in Parkinson’s disease: A Resting-State fMRI Study

    T. Yuan, L. Kai, S. Wen (Beijing, China)

    Objective: We aimed to test the differences of dynamic regional homogeneity (dReHo) between PD patients and healthy controls (HCs), and explore whether dReHo can be…
  • 2022 International Congress

    A low-cost system using a big-data deep-learning framework for assessing physical tele-rehabilitation: a proof-of-concept

    A. Olivares-Gil, JM. Ramírez-Sanz, JL. Garrido-Labrador, á. García-Bustillo, á. Arnaiz-González, JF. Díez-Pastor, J. González-Santos, JJ. González-Bernal, M. Allende-Río, F. Valiñas-Sieiro, JM. Trejo-Gabriel-Galan, E. Cubo (Burgos, Spain)

    Objective: The consolidation of tele-rehabilitation for the treatment of many diseases over the last decades is a result of its cost-effective results and its ability…
  • 2022 International Congress

    Paraneoplastic Cerebellar Ataxia Due To Ovarian Teratoma: A Case Report

    R. Zouari, C. Jeridi, F. Nabli, MZ. Saeid, S. Blel, S. Ben Sassi (tunis, Tunisia)

    Objective: report the case of a young woman who presented with rapidly progressive ataxia caused by an ovarian teratoma Background: paraneoplastic cerebellar degeneration (PCD) is…
  • 2022 International Congress

    Influence of dopaminergig medication and subthalamic nucleus deep brain stimulation on impulsive decision making in Parkinson’s disease

    JC. Baldermann, A. Nehs, H. Jergas, H. Dafsari, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To investigate how impulsive decision making is modulated by regular dopaminergic medication and by switching between active contacts of subthalamic nucleus stimulation Background: Impulsive…
  • 2022 International Congress

    Color vision deficits in Parkinson’s disease are linked to brain abnormalities in attentional, fronto-pariental and visual networks

    M. Diez-Cirarda, A. Murueta-Goyena, A. Miscioscia, R. Del Pino, S. Teijeira, MA. Acera, O. Lucas-Jimenez, N. Ojeda, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: To analyze the relationship between color vision deficits in Parkinson’s disease (PD) and the integrity of the visual system, cognition and other relevant networks…
  • 2022 International Congress

    Characteristics and Techniques to Improve Micrographia in Parkinson’s Disease

    S. Shahid (Southampton, USA)

    Objective: To analyze and identify the characteristics found in micrographia and provide methods of improving the symptom. Background: Micrographia, also known as small handwriting, is…
  • 2022 International Congress

    More than medications: Patient and care partner perspectives on care for Parkinson’s during hospitalization

    J. Shurer, N. Browner (New York, USA)

    Objective: To document and assess the needs, experiences, and self-reported challenges among patients and care partners that impact optimal care for Parkinson's disease (PD) during hospitalization.…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley